<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39327060</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2399-9772</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>26</Day></PubDate></JournalIssue><Title>BMJ paediatrics open</Title><ISOAbbreviation>BMJ Paediatr Open</ISOAbbreviation></Journal><ArticleTitle>Spatiotemporal analysis of the association between Kawasaki disease incidence and PM<sub>2.5</sub> exposure: a nationwide database study in Japan.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e002887</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjpo-2024-002887</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Kawasaki disease (KD) is an acute vasculitis primarily affecting children. While some studies suggest a link between KD and PM<sub>2.5</sub> exposure, findings remain inconsistent. This study aimed to perform spatiotemporal analysis to investigate the impact of monthly and annual exposure to PM<sub>2.5</sub> and other air pollutants on the incidence of KD before and after the advent of the COVID-19 pandemic.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this retrospective analysis, we used the Japanese administrative claims database to identify the incidence of KD in children under age 5 in 335 secondary medical care areas across Japan before (from July 2014 to December 2019) and during (from January 2020 to December 2021) the COVID-19 pandemic. For each of these periods, we developed hierarchical Bayesian models termed conditional autoregressive (CAR) models that can address the spatiotemporal clustering of KD to investigate the association between the monthly incidence of KD and exposure to PM<sub>2.5</sub>, NO, NO<sub>2</sub> and SO<sub>2</sub> over 1-month and 12-month durations. The pollution data were collected from publicly available data provided by the National Institute for Environmental Studies.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In the before-pandemic and during-pandemic periods, 55 289 and 14 023 new cases of KD were identified, respectively. The CAR models revealed that only 12-month exposure to PM<sub>2.5</sub> was consistently correlated with KD incidence, and each 1 µg/m<sup>3</sup> increase in annual PM<sub>2.5</sub> exposure corresponded to a 3%-10% rise in KD incidence. Consistent outcomes were observed in the age-stratified sensitivity analysis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Annual exposure to PM<sub>2.5</sub> was robustly linked with the onset of KD. Further research is needed to elucidate the underlying mechanism by which the spatiotemporal distribution of PM<sub>2.5</sub> is associated with KD.</AbstractText><CopyrightInformation>© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yoneda</LastName><ForeName>Kota</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-1605-5340</Identifier><AffiliationInfo><Affiliation>Health Policy and Informatics, Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences, Bunkyo-ku, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, The University of Tokyo Hospital, Bunkyo-ku, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shinjo</LastName><ForeName>Daisuke</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-7495-7409</Identifier><AffiliationInfo><Affiliation>Health Policy and Informatics, Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences, Bunkyo-ku, Japan dshinjo.hci@tmd.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Naoto</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, The University of Tokyo Hospital, Bunkyo-ku, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fushimi</LastName><ForeName>Kiyohide</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Health Policy and Informatics, Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences, Bunkyo-ku, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Paediatr Open</MedlineTA><NlmUniqueID>101715309</NlmUniqueID><ISSNLinking>2399-9772</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D052638">Particulate Matter</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000393">Air Pollutants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D009080" MajorTopicYN="Y">Mucocutaneous Lymph Node Syndrome</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D052638" MajorTopicYN="Y">Particulate Matter</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062211" MajorTopicYN="Y">Spatio-Temporal Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000393" MajorTopicYN="Y">Air Pollutants</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004781" MajorTopicYN="Y">Environmental Exposure</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000397" MajorTopicYN="N">Air Pollution</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Child Health</Keyword><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Statistics</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>21</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39327060</ArticleId><ArticleId IdType="pmc">PMC11428985</ArticleId><ArticleId IdType="doi">10.1136/bmjpo-2024-002887</ArticleId><ArticleId IdType="pii">10.1136/bmjpo-2024-002887</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi. 1967;16:178–222.</Citation><ArticleIdList><ArticleId IdType="pubmed">6062087</ArticleId></ArticleIdList></Reference><Reference><Citation>Ae R, Makino N, Kosami K, et al. Epidemiology, Treatments, and Cardiac Complications in Patients with Kawasaki Disease: The Nationwide Survey in Japan, 2017-2018. J Pediatr. 2020;225:23–9. doi: 10.1016/j.jpeds.2020.05.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2020.05.034</ArticleId><ArticleId IdType="pubmed">32454114</ArticleId></ArticleIdList></Reference><Reference><Citation>McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation. 2017;135:e927–99. doi: 10.1161/CIR.0000000000000484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000484</ArticleId><ArticleId IdType="pubmed">28356445</ArticleId></ArticleIdList></Reference><Reference><Citation>Furusho K, Kamiya T, Nakano H, et al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet. 1984;2:1055–8. doi: 10.1016/s0140-6736(84)91504-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(84)91504-6</ArticleId><ArticleId IdType="pubmed">6209513</ArticleId></ArticleIdList></Reference><Reference><Citation>Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991;324:1633–9. doi: 10.1056/NEJM199106063242305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199106063242305</ArticleId><ArticleId IdType="pubmed">1709446</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi T, Saji T, Otani T, et al. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet. 2012;379:1613–20. doi: 10.1016/S0140-6736(11)61930-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)61930-2</ArticleId><ArticleId IdType="pubmed">22405251</ArticleId></ArticleIdList></Reference><Reference><Citation>Miura M, Ayusawa M, Fukazawa R, et al. Guidelines for Medical Treatment of Acute Kawasaki Disease (2020 Revised Version) J Pediatr Cardiol Cardiac Surg. 2021;5:41–73. doi: 10.24509/jpccs.0501G1.</Citation><ArticleIdList><ArticleId IdType="doi">10.24509/jpccs.0501G1</ArticleId></ArticleIdList></Reference><Reference><Citation>Iio K, Matsubara K, Miyakoshi C, et al. Incidence of Kawasaki disease before and during the COVID-19 pandemic: a retrospective cohort study in Japan. BMJ Paediatr Open . 2021;5:e001034. doi: 10.1136/bmjpo-2021-001034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjpo-2021-001034</ArticleId><ArticleId IdType="pmc">PMC8023747</ArticleId><ArticleId IdType="pubmed">33884312</ArticleId></ArticleIdList></Reference><Reference><Citation>Yorifuji T, Tsukahara H, Kashima S, et al. Intrauterine and Early Postnatal Exposure to Particulate Air Pollution and Kawasaki Disease: A Nationwide Longitudinal Survey in Japan. J Pediatr. 2018;193:147–54. doi: 10.1016/j.jpeds.2017.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2017.10.012</ArticleId><ArticleId IdType="pubmed">29212623</ArticleId></ArticleIdList></Reference><Reference><Citation>Buteau S, Belkaibech S, Bilodeau-Bertrand M, et al. Association between Kawasaki Disease and Prenatal Exposure to Ambient and Industrial Air Pollution: A Population-Based Cohort Study. Environ Health Perspect. 2020;128:107006. doi: 10.1289/EHP6920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1289/EHP6920</ArticleId><ArticleId IdType="pmc">PMC7571626</ArticleId><ArticleId IdType="pubmed">33074736</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H, Jang H, Lee W, et al. Association between long-term PM2.5 exposure and risk of Kawasaki disease in children: A nationwide longitudinal cohort study. Environ Res. 2024;244:117823. doi: 10.1016/j.envres.2023.117823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envres.2023.117823</ArticleId><ArticleId IdType="pubmed">38072109</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodó X, Ballester J, Cayan D, et al. Association of Kawasaki disease with tropospheric wind patterns. Sci Rep. 2011;1:152. doi: 10.1038/srep00152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep00152</ArticleId><ArticleId IdType="pmc">PMC3240972</ArticleId><ArticleId IdType="pubmed">22355668</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeft AS, Burns JC, Yeung RS, et al. Kawasaki Disease and Exposure to Fine Particulate Air Pollution. J Pediatr. 2016;177:179–83. doi: 10.1016/j.jpeds.2016.06.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2016.06.061</ArticleId><ArticleId IdType="pubmed">27496266</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh J, Lee JH, Kim E, et al. Is Short-Term Exposure to PM2.5 Relevant to Childhood Kawasaki Disease? IJERPH. 2021;18:924. doi: 10.3390/ijerph18030924.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18030924</ArticleId><ArticleId IdType="pmc">PMC7908497</ArticleId><ArticleId IdType="pubmed">33494415</ArticleId></ArticleIdList></Reference><Reference><Citation>Yashiro M, Nakamura Y, Ojima T, et al. Ten Year Observation of Time-space Relationship on Incidences of Kawasaki Disease in Japan, Analyses in Hokkaido and Shikoku. J Jpn Pediatr Soc. 1999;103:832–7.</Citation></Reference><Reference><Citation>Nakamura Y, Yashiro M, Uehara R, et al. Monthly observation of the number of patients with Kawasaki disease and its incidence rates in Japan: chronological and geographical observation from nationwide surveys. J Epidemiol. 2008;18:273–9. doi: 10.2188/jea.je2008030.</Citation><ArticleIdList><ArticleId IdType="doi">10.2188/jea.je2008030</ArticleId><ArticleId IdType="pmc">PMC4771612</ArticleId><ArticleId IdType="pubmed">19075496</ArticleId></ArticleIdList></Reference><Reference><Citation>Sano T, Makino N, Aoyama Y, et al. Temporal and geographical clustering of Kawasaki disease in Japan: 2007-2012. Pediatr Int. 2016;58:1140–5. doi: 10.1111/ped.12970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ped.12970</ArticleId><ArticleId IdType="pubmed">26940079</ArticleId></ArticleIdList></Reference><Reference><Citation>Burney JA, DeHaan LL, Shimizu C, et al. Temporal clustering of Kawasaki disease cases around the world. Sci Rep. 2021;11:22584. doi: 10.1038/s41598-021-01961-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-01961-5</ArticleId><ArticleId IdType="pmc">PMC8605018</ArticleId><ArticleId IdType="pubmed">34799633</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, Hong K, Yoo D, et al. Spatiotemporal clusters of Kawasaki disease in South Korea from 2008 to 2017: A municipal-level ecological study. Front Pediatr. 2022;10:1054985. doi: 10.3389/fped.2022.1054985.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.1054985</ArticleId><ArticleId IdType="pmc">PMC9904408</ArticleId><ArticleId IdType="pubmed">36760687</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D. CARBayes: An R Package for Bayesian Spatial Modeling with Conditional Autoregressive Priors. J Stat Softw. 2013;55:1–24. doi: 10.18637/jss.v055.i13.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v055.i13</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D, Rushworth A, Napier G. Spatio-Temporal Areal Unit Modeling in R with Conditional Autoregressive Priors Using the CARBayesST Package. J Stat Softw. 2018;84:1–39. doi: 10.18637/jss.v084.i09.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v084.i09</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Haining RP, Li G. Modelling Spatial and Spatial-Temporal Data: A Bayesian Approach. Chapman and Hall/CRC; 2020.</Citation></Reference><Reference><Citation>Ae R, Makino N, Kuwabara M, et al. Incidence of Kawasaki Disease Before and After the COVID-19 Pandemic in Japan: Results of the 26th Nationwide Survey, 2019 to 2020. JAMA Pediatr. 2022;176:1217–24. doi: 10.1001/jamapediatrics.2022.3756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2022.3756</ArticleId><ArticleId IdType="pmc">PMC9577881</ArticleId><ArticleId IdType="pubmed">36251290</ArticleId></ArticleIdList></Reference><Reference><Citation>Burney JA, Roberts SC, DeHaan LL, et al. Epidemiological and Clinical Features of Kawasaki Disease During the COVID-19 Pandemic in the United States. JAMA Netw Open . 2022;5:e2217436. doi: 10.1001/jamanetworkopen.2022.17436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.17436</ArticleId><ArticleId IdType="pmc">PMC9206189</ArticleId><ArticleId IdType="pubmed">35713905</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamana H, Moriwaki M, Horiguchi H, et al. Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. J Epidemiol. 2017;27:476–82. doi: 10.1016/j.je.2016.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.je.2016.09.009</ArticleId><ArticleId IdType="pmc">PMC5602797</ArticleId><ArticleId IdType="pubmed">28142051</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Environmental Studies  Air pollution continuous monitoring data. https://tenbou.nies.go.jp n.d. Available.</Citation></Reference><Reference><Citation>Population Census  Portal site of official statistics of Japan. 2020. https://www.e-stat.go.jp/en/stat-search/files?page=1&amp;toukei=00200521&amp;tstat=000001136464 Available.</Citation></Reference><Reference><Citation>Leroux BG, Lei X, Breslow N. Estimation of Disease Rates in Small Areas: A New Mixed Model for Spatial Dependence. New York: Springer; 2000. pp. 179–91.</Citation></Reference><Reference><Citation>R Core Team R: a language and environment for statistical computing. 2023</Citation></Reference><Reference><Citation>Rushworth A, Lee D, Mitchell R. A spatio-temporal model for estimating the long-term effects of air pollution on respiratory hospital admissions in Greater London. Spat Spatiotemp Epidemiol. 2014;10:29–38. doi: 10.1016/j.sste.2014.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sste.2014.05.001</ArticleId><ArticleId IdType="pubmed">25113589</ArticleId></ArticleIdList></Reference><Reference><Citation>Rushworth A, Lee D, Sarran C. An Adaptive Spatiotemporal Smoothing Model for Estimating Trends and Step Changes in Disease Risk. J R Stat Soc Ser C Appl Stat. 2017;66:141–57. doi: 10.1111/rssc.12155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/rssc.12155</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S. Asymptotic Equivalence of Bayes Cross Validation and Widely Applicable Information Criterion in Singular Learning Theory. J Mach Learn Res. 2010;11:3571–94. doi: 10.5555/1756006.1953045.</Citation><ArticleIdList><ArticleId IdType="doi">10.5555/1756006.1953045</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Bechle MJ, Kim S-Y, et al. Spatial decomposition analysis of NO2 and PM2.5 air pollution in the United States. Atmos Environ (1994) 2020;241:117470. doi: 10.1016/j.atmosenv.2020.117470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atmosenv.2020.117470</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraigneau Y, Gonzalez M, Coppalle A. Turbulence effects upon the NO2/NO conversion in the vicinity of an urban area. Sci Total Environ. 1996;189–190:293–300. doi: 10.1016/0048-9697(96)05222-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0048-9697(96)05222-9</ArticleId><ArticleId IdType="pubmed">8865679</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Wu W, Li Y, et al. An investigation of PM2.5 concentration changes in Mid-Eastern China before and after COVID-19 outbreak. Environ Int. 2023;175:107941. doi: 10.1016/j.envint.2023.107941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envint.2023.107941</ArticleId><ArticleId IdType="pmc">PMC10119641</ArticleId><ArticleId IdType="pubmed">37146469</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann EL, Casella G. Normal Linear Models. New York:: Springer; 1998. pp. 176–87.</Citation></Reference><Reference><Citation>Majumdar S, Flynn C, Mitra R. Detecting Bias in the Presence of Spatial Autocorrelation. Proc Mach Learn Res. 2022;171:6–18.</Citation></Reference><Reference><Citation>Matasubara D, Matsubara Y, Ayusawa M, et al. Nationwide survey of multisystem inflammatory syndrome in children associated with coronavirus disease 2019 in Japan. SSRN. 2024 doi: 10.2139/ssrn.4787473. Preprint.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.4787473</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodó X, Curcoll R, Robinson M, et al. Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan. Proc Natl Acad Sci U S A. 2014;111:7952–7. doi: 10.1073/pnas.1400380111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1400380111</ArticleId><ArticleId IdType="pmc">PMC4050536</ArticleId><ArticleId IdType="pubmed">24843117</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Askary H, LaHaye N, Linstead E, et al. Remote sensing observation of annual dust cycles and possible causality of Kawasaki disease outbreaks in Japan. Glob Cardiol Sci Pract. 2017;2017:e201722. doi: 10.21542/gcsp.2017.22.</Citation><ArticleIdList><ArticleId IdType="doi">10.21542/gcsp.2017.22</ArticleId><ArticleId IdType="pmc">PMC5856959</ArticleId><ArticleId IdType="pubmed">29564343</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Di Q. Modifiable areal unit problem and environmental factors of COVID-19 outbreak. Sci Total Environ. 2020;740:139984. doi: 10.1016/j.scitotenv.2020.139984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scitotenv.2020.139984</ArticleId><ArticleId IdType="pmc">PMC7274979</ArticleId><ArticleId IdType="pubmed">32534259</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>